It was the purpose of this study to determine the number and character of peripheral neuropathic reactions in a large group of patients receiving isoniazid in dosages of 8 to 16 mg. per kilogram ...
Our objective was to evaluate the efficacy of isoniazid in prevention of tuberculosis morbidity and mortality in children aged 15 years or younger by performing a meta-analysis of randomized ...
The union government has approved a shorter and more effective treatment regimen for multi-drug-resistant tuberculosis. This ...
Considering taking supplements to treat isoniazid induced neuropathy? Below is a list of common natural remedies used to treat or reduce the symptoms of isoniazid induced neuropathy. Follow the ...
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
Nigeria, in collaboration with the Lagos State TB Control Programme, has organised a three-day training for journalists to ...
Discover the commercial and brand names of the generic drug Isoniazid. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to understand ...
Tuberculosis (TB) continues to be a major public health challenge in India, which bears the world’s highest burden of the ...
The most used preventive therapy is a course of isoniazid taken daily for six to nine months. • In some cases, especially for individuals at higher risk of TB reactivation, shorter regimens such as ...
May potentiate cyclosporine (seizure risk). May antagonize oral anticoagulants (monitor), isoniazid. Increased risk of arrhythmias with digitalis. May need to adjust dose of antidiabetic agents.
May potentiate cyclosporine. May antagonize anticoagulants (monitor), isoniazid, other CYP3A4 substrates (eg, indinavir, erythromycin). Increased risk of arrhythmias with digitalis. May need to ...
Acute liver failure (ALF) in children differs from that observed in adults in both the etiologic spectrum and the clinical picture. Children, particularly very young ones, do not demonstrate ...